Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Safety and Efficacy of Artemether-Lumefantrine Tablets in African Infants and Children With Uncomplicated P. Falciparum Malaria

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* male or female weighing ≥ 5kg and ≤ 25kg~* P. falciparum parasitemia between 1,000 and 100,000 parasites/mm3~* with confirmed diagnosis of uncomplicated malaria caused P. falciparum parasite~Exclusion Criteria:~* complicated malaria~* ingestion of various antimalarial drugs, or other drugs influencing cardiac function in the previous 4 weeks before study entry to 8 weeks~* severe anaemia~* severe malnutrition~* malaria due to other than P. falciparum~Other protocol-defined inclusion/exclusion criteria may apply

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: None

Study Arms:
- 1 (Type: EXPERIMENTAL): Artemether-lumefantrine

Based on this trial design, predict the completion outcome and termination type (if applicable).